Hetriva 4.6mg Patch
Prescription Required
Product introduction
Hetriva 4.6mg Patch is used to treat mild to moderate dementia in Alzheimer’s disease, a progressive illness which gradually affects memory and thinking. It is also used to treat Parkinson’s disease. It does not cure these illnesses but may help improve memory, awareness and other symptoms.
Hetriva 4.6mg Patch is used to treat symptoms of Alzheimer's disease that include memory loss, confusion and behaviour changes
Hetriva 4.6mg Patch is used to treat symptoms of Alzheimer's disease that include memory loss, confusion and behaviour changes
Uses of Hetriva Patch
- Alzheimer's disease
Benefits of Hetriva Patch
In Alzheimer's disease
In people with Alzheimer’s disease, certain nerve cells die in the brain. This results in lower levels of a chemical called acetylcholine which helps nerve cells to communicate with each other. This leads to symptoms of dementia such as memory loss, confusion, disorientation, problems with speech and language, and personality changes. Hetriva 4.6mg Patch increases the amount of acetylcholine and helps brain cells to communicate. It can, therefore, improve some of the symptoms such as memory, awareness, and the ability to carry out daily functions for a time. However, it is not a cure.
You should use the patches exactly as they have been prescribed and only use one at a time. Choose a different place on your body to wear the patch each time you put on a new one. It can take several weeks for your symptoms to improve; so keep applying the patches even if you do not think they are working.
You should use the patches exactly as they have been prescribed and only use one at a time. Choose a different place on your body to wear the patch each time you put on a new one. It can take several weeks for your symptoms to improve; so keep applying the patches even if you do not think they are working.
Side effects of Hetriva Patch
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Hetriva
- Nausea
- Vomiting
- Indigestion
- Loss of appetite
How to use Hetriva Patch
Use this medicine in dose and duration as advised by your doctor. Check the label before use. Make sure the skin is clean and dry. Remove the protective liner of the patch. Do not touch the sticky side. With sticky side down, place the patch evenly onto the skin.
Safety advice
Alcohol
No interaction found/established
Pregnancy
SAFE IF PRESCRIBED
Hetriva 4.6mg Patch is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Breast feeding
CONSULT YOUR DOCTOR
Hetriva 4.6mg Patch is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
No interaction found/established
Kidney
No interaction found/established
Liver
No interaction found/established
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- You have been prescribed Hetriva 4.6mg Patch to slow down the progression of Alzheimer's disease.
- It does not cure Alzheimer's disease but may help improve brain function and ability to do daily activities.
- It may cause diarrhea, nausea, and vomiting. Drink plenty of fluids to keep yourself hydrated while taking Hetriva 4.6mg Patch.
- Do not drive or do anything that requires mental focus until you know how Hetriva 4.6mg Patch affects you.
- Be cautious while taking this medicine if you suffer from peptic ulcer as it may cause vomiting, stomach bleeding, stomach pain, or discomfort.
- Inform your doctor if you experience seizures or convulsions while taking this medicine.
Fact Box
Chemical Class
Carbamate Derivative
Habit Forming
No
Therapeutic Class
NEURO CNS
Action Class
Cholinesterase inhibitors - Alzheimer's disease
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Stahl SM, editor. Rivastigmine. In: Stahl's Essential Pschopharmacology: Prescriber's Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 603-607.
- Katzung BG. Special Aspects of Geriatric Pharmacology. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 1041.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1229.
- Rivastigmine. Camberley, Surrey: Novartis Pharmaceuticals UK Ltd.; 2008 [revised 23 Apr. 2018]. [Accessed 22 Mar. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 22 Mar. 2019] (online) Available from:
Marketer details
Name: Hetero Healthcare Limited
Address: S.no: 80-84, Melange towers, PatrikaNagar,Madhapur,Hyderabad. Telangana-500081.
Country of origin: India
Lab tests offered by us
Related/Popular tests
226 people viewed this recentlyMRP
₹65
Inclusive of all taxes
1.0 Patch in 1 packet
SOLD OUT
Notify me